These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 2893876

  • 1. Could an endogenous benzodiazepine ligand contribute to hepatic encephalopathy?
    Mullen KD, Martin JV, Mendelson WB, Bassett ML, Jones EA.
    Lancet; 1988 Feb 27; 1(8583):457-9. PubMed ID: 2893876
    [Abstract] [Full Text] [Related]

  • 2. Increased brain concentrations of endogenous (non-benzodiazepine) GABA-A receptor ligands in human hepatic encephalopathy.
    Ahboucha S, Pomier-Layrargues G, Butterworth RF.
    Metab Brain Dis; 2004 Dec 27; 19(3-4):241-51. PubMed ID: 15554420
    [Abstract] [Full Text] [Related]

  • 3. Benzodiazepine receptor ligands and hepatic encephalopathy: further unfolding of the GABA story.
    Jones EA.
    Hepatology; 1991 Dec 27; 14(6):1286-90. PubMed ID: 1660022
    [No Abstract] [Full Text] [Related]

  • 4. NIH conference. The gamma-aminobutyric acid A (GABAA) receptor complex and hepatic encephalopathy. Some recent advances.
    Jones EA, Skolnick P, Gammal SH, Basile AS, Mullen KD.
    Ann Intern Med; 1989 Apr 01; 110(7):532-46. PubMed ID: 2538099
    [Abstract] [Full Text] [Related]

  • 5. Differential responsiveness of cerebellar Purkinje neurons to GABA and benzodiazepine receptor ligands in an animal model of hepatic encephalopathy.
    Basile AS, Gammal SH, Mullen KD, Jones EA, Skolnick P.
    J Neurosci; 1988 Jul 01; 8(7):2414-21. PubMed ID: 2854841
    [Abstract] [Full Text] [Related]

  • 6. Amelioration of hepatic encephalopathy by pharmacologic antagonism of the GABAA-benzodiazepine receptor complex in a rabbit model of fulminant hepatic failure.
    Bassett ML, Mullen KD, Skolnick P, Jones EA.
    Gastroenterology; 1987 Nov 01; 93(5):1069-77. PubMed ID: 2820828
    [Abstract] [Full Text] [Related]

  • 7. Hepatic encephalopathy, GABA-ergic neurotransmission and benzodiazepine receptor ligands.
    Jones EA, Basile AS, Skolnick P.
    Adv Exp Med Biol; 1990 Nov 01; 272():121-34. PubMed ID: 1966504
    [Abstract] [Full Text] [Related]

  • 8. An interaction between benzodiazepines and neuroactive steroids at GABA A receptors in cultured hippocampal neurons.
    Ahboucha S, Coyne L, Hirakawa R, Butterworth RF, Halliwell RF.
    Neurochem Int; 2006 Jun 01; 48(8):703-7. PubMed ID: 16487630
    [Abstract] [Full Text] [Related]

  • 9. Reversal of the behavioral and electrophysiological abnormalities of an animal model of hepatic encephalopathy by benzodiazepine receptor ligands.
    Gammal SH, Basile AS, Geller D, Skolnick P, Jones EA.
    Hepatology; 1990 Mar 01; 11(3):371-8. PubMed ID: 2155865
    [Abstract] [Full Text] [Related]

  • 10. Benzodiazepine receptor ligands are elevated in an animal model of hepatic encephalopathy: relationship between brain concentration and severity of encephalopathy.
    Yurdaydin C, Gu ZQ, Nowak G, Fromm C, Holt AG, Basile AS.
    J Pharmacol Exp Ther; 1993 May 01; 265(2):565-71. PubMed ID: 8388453
    [Abstract] [Full Text] [Related]

  • 11. Beneficial effect of pharmacological modulation of the GABAA-benzodiazepine receptor on hepatic encephalopathy in the rat: comparison with uremic encephalopathy.
    Steindl P, Püspök A, Druml W, Ferenci P.
    Hepatology; 1991 Dec 01; 14(6):963-8. PubMed ID: 1660024
    [Abstract] [Full Text] [Related]

  • 12. Hemoglobin metabolites mimic benzodiazepines and are possible mediators of hepatic encephalopathy.
    Ruscito BJ, Harrison NL.
    Blood; 2003 Aug 15; 102(4):1525-8. PubMed ID: 12714506
    [Abstract] [Full Text] [Related]

  • 13. Elevated brain concentrations of 1,4-benzodiazepines in fulminant hepatic failure.
    Basile AS, Hughes RD, Harrison PM, Murata Y, Pannell L, Jones EA, Williams R, Skolnick P.
    N Engl J Med; 1991 Aug 15; 325(7):473-8. PubMed ID: 1649403
    [Abstract] [Full Text] [Related]

  • 14. A benzodiazepine antagonist does not alter the course of hepatic encephalopathy or neural gamma-aminobutyric acid (GABA) binding.
    Zieve L, Ferenci P, Rzepczynski D, Ebner J, Zimmermann C.
    Metab Brain Dis; 1987 Sep 15; 2(3):201-5. PubMed ID: 2850457
    [Abstract] [Full Text] [Related]

  • 15. Supersensitivity of benzodiazepine receptors in hepatic encephalopathy due to fulminant hepatic failure in the rat: reversal by a benzodiazepine antagonist.
    Baraldi M, Zeneroli ML, Ventura E, Penne A, Pinelli G, Ricci P, Santi M.
    Clin Sci (Lond); 1984 Aug 15; 67(2):167-75. PubMed ID: 6086210
    [Abstract] [Full Text] [Related]

  • 16. Role of endogenous benzodiazepine ligands and their GABA-A--associated receptors in hepatic encephalopathy.
    Ahboucha S, Butterworth RF.
    Metab Brain Dis; 2005 Dec 15; 20(4):425-37. PubMed ID: 16382352
    [Abstract] [Full Text] [Related]

  • 17. The role of endogenous benzodiazepines in hepatic encephalopathy: animal studies.
    Jones EA, Yurdaydin C, Basile AS.
    Alcohol Alcohol Suppl; 1993 Dec 15; 2():175-80. PubMed ID: 7748296
    [Abstract] [Full Text] [Related]

  • 18. [Ammonia and GABA-ergic neurotransmission in pathogenesis of hepatic encephalopathy].
    Helewski K, Kowalczyk-Ziomek G, Konecki J.
    Wiad Lek; 2003 Dec 15; 56(11-12):560-3. PubMed ID: 15058165
    [Abstract] [Full Text] [Related]

  • 19. Endogenous GABAergic modulators in the pathogenesis of hepatic encephalopathy.
    Rothstein JD, Olasmaa M.
    Neurochem Res; 1990 Feb 15; 15(2):193-7. PubMed ID: 2159124
    [Abstract] [Full Text] [Related]

  • 20. The effects of benzodiazepine-receptor antagonists and partial inverse agonists on acute hepatic encephalopathy in the rat.
    Bosman DK, van den Buijs CA, de Haan JG, Maas MA, Chamuleau RA.
    Gastroenterology; 1991 Sep 15; 101(3):772-81. PubMed ID: 1650320
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.